SEOM-GETNE clinical guidelines for the diagnosis and treatment of gastroenteropancreatic and bronchial neuroendocrine neoplasms (NENs) (2022)
Clin. transl. oncol. (Print)
; 25(9): 2692-2706, sept. 2023. ilus
Article
in English
| IBECS
| ID: ibc-224134
Responsible library:
ES1.1
Localization: ES15.1 - BNCS
ABSTRACT
'Neuroendocrine neoplasms (NENs) are a heterogeneous family of tumors of challenging diagnosis and clinical management. Their incidence and prevalence continue to rise mainly due to an improvement on diagnostic techniques and awareness. Earlier detection, along with steadfast improvements in therapy, has led to better prognosis over time for advanced gastrointestinal and pancreatic neuroendocrine tumors. The aim of this guideline is to update evidence-based recommendations for the diagnosis and treatment of gastroenteropancreatic and lung NENs. Diagnostic procedures, histological classification, and therapeutic options, including surgery, liver-directed therapy, peptide receptor radionuclide therapy, and systemic hormonal, cytotoxic or targeted therapy, are reviewed and discussed, and treatment algorithms to guide therapeutic decisions are provided (AU)
Full text:
Available
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Stomach Neoplasms
/
Bronchial Neoplasms
/
Neuroendocrine Tumors
/
Intestinal Neoplasms
Limits:
Humans
Country/Region as subject:
Europa
Language:
English
Journal:
Clin. transl. oncol. (Print)
Year:
2023
Document type:
Article
Institution/Affiliation country:
Hospital General Universitario de Elche/Spain
/
Hospital Universitari I Politècnic la Fe/Spain
/
Hospital Universitario 12 de Octubre/Spain
/
Hospital Universitario Central de Asturias/Spain
/
Hospital Universitario Fundación Jiménez Díaz/Spain
/
Hospital Universitario La Paz/Spain
/
Hospital Universitario Morales Meseguer/Spain
/
Hospital Universitario Ramón y Cajal/Spain
/
MD Anderson Cancer Center/Spain
/
Ps Vall dHebron/Spain